SCHEMBL7924324

SCHEMBL7924324

CC(=O)CCC(C)Cc1ccccc1C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.36
LMNA P02545 1/20 0.35
TSHR P16473 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HPGD P15428 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
IAPP P10997 1/20 0.34
RBP4 P02753 3/20 0.33
NPSR1 Q6W5P4 1/20 0.32
CA2 P00918 1/20 0.32
KDM4E B2RXH2 2/20 0.31
GAA P10253 1/20 0.31
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
RXRG P48443 1/20 0.31
ALOX5 P09917 1/20 0.31
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9720280 0.77 ALDH1A1 (0.41) ALDH1A1TSHRTDP1HPGDNPC1
SCHEMBL16393721 0.74 ALDH1A1 (0.52) ALDH1A1TSHRTDP1RBP4KDM4E
SCHEMBL13235780 0.74 ALDH1A1 (0.55) ALDH1A1LMNANPC1RAB9APTGS1
SCHEMBL10398717 0.74 ALDH1A1 (0.36) ALDH1A1TSHRTDP1CA2GAA
SCHEMBL20208030 0.74 ALDH1A1 (0.55) ALDH1A1LMNANPC1RAB9APTGS1
SCHEMBL8975793 0.73 L3MBTL1 (0.46) ALDH1A1TSHRTDP1RBP4CA2
SCHEMBL11435958 0.73 GABRA1 (0.48) ALDH1A1TSHRTDP1CA2
SCHEMBL7924328 0.72 TP53 (0.50) TSHR
SCHEMBL25956026 0.71 ALDH1A1 (0.36) ALDH1A1TSHRTDP1RBP4NPSR1
SCHEMBL23581846 0.70 NOS3 (0.55) ALDH1A1LMNATSHRTDP1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303823-B2 ?CROSSED ALDOL CONDENSATION? OF A KETONE WITH AN ALDEHYDE IN THE PRESENCE OF A CATALYST SYSTEM CONSISTING OF DIMETHYLAMINE OR PYRROLIDINE AND A CARBOXYLIC ACID TO FORM AN ALPHA,BETA-UNSATURATED KETONE BASF AKTIENGESELLSCHAFT (DE) 2001-10-16 US disclosed
US-20010003784-A1 Process for preparing ketones, in particular 6-methylheptan-2-one BASF AKTIENGESELLSCAFT (DE) 2001-06-14 US disclosed
EP-1106597-A1 Process for the preparation of ketones, especially 6-methyl-heptan-2-one BASF AKTIENGESELLSCHAFT (DE) 2001-06-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010003784-A1 Process for preparing ketones, in particular 6-methylheptan-2-one ADH1A, ADH1C, ADH5 ALDH1A1 54/4885LMNA 733/4885TSHR 3537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.